4D Molecular Therapeutics Inc.
4DMT Highlights Robust and Durable Clinical Activity for 4D 150 and[...]
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030,[...]
01/31/2023 | Press release | Distributed by Public on 01/31/2023 07:50
Please select the service you want to use:
Smartlinks | SenesTech Inc. | News | Health | Company News | Top Company News | Agriculture | Manufacturing | Pharmaceuticals | Food Industry | Public Companies | Animal Pharmaceutical Companies | Frankfurt Stock Exchange | Stuttgart Stock Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact